Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Baird Small/Mid Cap Growth Equity Fund 2024 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (Baird Small/Mid Cap Growth Equity Fund)

Primary Source Intelligence • Q2 2024 Letter Analysis

Baird Small/Mid Cap Growth Equity Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Baird Small/Mid Cap Growth Equity Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+9.13%

Digest Analysis

Quick Take

"Baird Small/Mid Cap Growth underperformed in Q2 as market concentration in large-cap tech continued pressuring smaller stocks. The team actively repositioned the portfolio, adding defense contractor CACI, software names, and healthcare innovators while exiting underperformers."

Executive Summary

Baird Small/Mid Cap Growth portfolio declined 5.7% net in Q2 2024, underperforming the Russell 2500 Growth Index by 150 basis points. Performance reflected the continued market concentration in larger technology stocks while small and mid-cap indices declined. The manager made significant portfolio adjustments, adding five new positions and exiting five others to strengthen the portfolio. Technology was the best performing sector driven by software holdings and semiconductor positions, while healthcare and consumer discretionary detracted from performance. Notable additions included CACI benefiting from defense spending, software companies like SPS Commerce and AppFolio, and healthcare names including Medpace and PROCEPT BioRobotics. Key detractors included Inspire Medical facing GLP-1 therapy concerns, Repligen dealing with CEO transition, and consumer names like Five Below and Pool Corp missing expectations. The manager remains confident in their investment process and ability to generate strong relative returns, expecting eventual broadening of market performance beyond the current narrow leadership.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

The manager demonstrates solid conviction through active portfolio management, adding five new positions with detailed investment rationales. Each new holding has a clear thesis and specific growth drivers. However, the diversified nature of the portfolio and acknowledgment of challenging conditions prevents a higher score.

Growth Outlook

38%

BearishBullish

Neutral (38%)

The manager expresses caution about market concentration in large-cap technology stocks and acknowledges challenging conditions for small and mid-cap stocks. While not deeply pessimistic, the tone reflects concern about narrow market leadership and performance headwinds.

Risk Appetite

25%

DefensiveAggressive

Defensive (25%)

The portfolio shows moderate risk appetite through active position additions and willingness to make significant changes. The manager added five new positions while maintaining conviction in their investment approach, indicating selective but constructive positioning.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

The portfolio shows modest net deployment through rotation activity - selling five positions and adding five new ones. This represents capital rotation rather than significant new cash deployment, indicating selective but not aggressive capital allocation.

Forward Guidance

0%

CautiousExpansionary

Cautious (0%)

The manager takes a balanced approach to future deployment, stating they will continue to adjust to the environment and make appropriate changes as warranted. No clear directional bias toward aggressive deployment or defensive positioning.

Language Signal

45%

BearishBullish

Balanced (45%)

Language is slightly more cautious than bullish, with references to underperformance periods, challenging conditions, and market concentration risks. However, this is balanced by confidence in their process and expectations for eventual mean reversion.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

The manager acknowledges moderate risks including market concentration, interest rate concerns, and sector-specific challenges. Risks are discussed but not characterized as systemic or extreme, representing standard market and portfolio-level concerns.

Opportunity Density

60%

ScarceAbundant

Selective (60%)

The manager identifies selective opportunities across multiple sectors, adding five new positions with compelling investment rationales. While acknowledging challenging market conditions, they demonstrate ability to find attractive ideas in defense, software, and healthcare sectors.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The investment approach reflects a multi-year time horizon with focus on structural growth drivers and company-specific catalysts. References to long-term positioning, mean reversion expectations, and willingness to hold through volatility indicate patient capital deployment over 2-3 year periods.